Aisha Zaidi in Williamsburg, Virginia

Home Virginia Williamsburg

Aisha Zaidi has Hematology as her primary medical specialty. Their primary office is: 120 Kings Way in Williamsburg, Virginia.

They're a part of the: Peninsula Cancer Institute, Llc medical group which has around 33 members. You can call their office at 757-345-5724 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2004 (around 20 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Aisha Salman Zaidi Office Phone and Directions

Aisha Zaidi
Peninsula Cancer Institute, Llc
120 Kings Way
Williamsburg, Virginia 23185
757-345-5724

Patient Ratings
Please rate your experience with Aisha Zaidi below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 757-345-5724

Enter a starting address:

Healthcare Info for Aisha Zaidi

Additional Medical Specialties Include:
INTERNAL MEDICINE, MEDICAL ONCOLOGY

Medical School: Sorry, her university is not listed
Graduation Year: 2004
The Primary Medical Specialty for Aisha Zaidi is listed as: Hematology
Approximate Years of Experience: 20
PAC (PECOS ID)#: 4082894985
NPI #: 1770770281
NPI Created On: 09/28/2007
NPI Last Updated Listed as: 07/02/2014
Primary Taxonomy Code: 207RH0003X
License Number:
0101256370
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
CareSource
Optima Health Plan
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Physician telephone patient service, 21-30 minutes of medical discussion
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818894219

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: RETEVMO

Associated Drug #2: 0002-2980-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813384383

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: KISQALI

Open Associated Drug #1: 0078-0860-01

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: FEMARA

Associated Drug #2: 0078-0249-15

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: PIQRAY

Name Of Drug #3: 0078-0708-02

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 826287411

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Kyprolis

Open Associated Drug #1: 76075-101-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843636281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ELITEK

Open Associated Drug #1: 0024-5151-75

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: SARCLISA

Associated Drug #2: 0024-0654-01

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843636285

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: SARCLISA

Open Associated Drug #1: 0024-0654-01

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: ELITEK

Associated Drug #2: 0024-5151-75

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843636319

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ELITEK

Open Associated Drug #1: 0024-5151-75

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: SARCLISA

Associated Drug #2: 0024-0654-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843636343

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ELITEK

Open Associated Drug #1: 0024-5151-75

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: SARCLISA

Associated Drug #2: 0024-0654-01

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843636367

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ELITEK

Open Associated Drug #1: 0024-5151-75

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: SARCLISA

Associated Drug #2: 0024-0654-01

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843636397

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ELITEK

Open Associated Drug #1: 0024-5151-75

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: SARCLISA

Associated Drug #2: 0024-0654-01

Payments Total: $119

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 834556087

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis

Name of Drug #1: myRisk

Providers in Peninsula Cancer Institute, Llc

1.Michail Alevizakos

110 Wimbledon Square
Chesapeake Va 23320-4946
Peninsula Cancer Institute, Llc
Hematology/oncology

2.Michail Alevizakos

1200 1st Colonial Rd
Virginia Beach Va 23454-2270
Peninsula Cancer Institute, Llc
Hematology/oncology

3.Kelly Armbruster

120 Kings Way
Williamsburg Va 23185-2506
Peninsula Cancer Institute, Llc
Nurse Practitioner

4.Kelly Armbruster

12100 Warwick Blvd
Newport News Va 23601-2365
Peninsula Cancer Institute, Llc
Nurse Practitioner

5.Ashrei Bayewitz

7544 Medical Dr
Gloucester Va 23061-4299
Peninsula Cancer Institute, Llc
Hematology/oncology

6.Ashrei Bayewitz

12100 Warwick Blvd
Newport News Va 23601-2365
Peninsula Cancer Institute, Llc
Hematology/oncology

View all 33 members of Peninsula Cancer Institute, Llc medical group